SpringWorks Therapeutics Inc (SWTX) — Capital Reinvestment Ratio
SpringWorks Therapeutics Inc (SWTX) has a Capital Reinvestment Ratio of 0.00x as of December 2020, meaning it reinvests 0% of its operating cash flow ($15.07 Million) in capital expenditures ($54.00K). See SpringWorks Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SpringWorks Therapeutics Inc Capital Reinvestment Ratio (2004–2010)
This chart tracks SpringWorks Therapeutics Inc's Capital Reinvestment Ratio across 7 annual periods. Check SpringWorks Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for SpringWorks Therapeutics Inc (2004–2010)
Year-by-year Capital Reinvestment Ratio for SpringWorks Therapeutics Inc from 2004 to 2010. For live market cap and broader valuation context, see how much is SpringWorks Therapeutics Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.34x | $5.61 Million | $1.89 Million | ▲ +2.1% |
| 2009 | 0.33x | $5.23 Million | $1.73 Million | ▲ +274.2% |
| 2008 | 0.09x | $7.10 Million | $626.00K | ▼ -29.3% |
| 2007 | 0.12x | $5.70 Million | $710.00K | ▼ -92.2% |
| 2006 | 1.59x | $748.00K | $1.19 Million | ▲ +733.4% |
| 2005 | 0.19x | $4.01 Million | $766.00K | ▲ +91.7% |
| 2004 | 0.10x | $3.83 Million | $382.00K | — |